Postmenopausal Hormone Therapy Market Forecast (2022-2027)

1
Postmenopausal Hormone Therapy MarketMarket
size, Industry outlook, Market Forecast, Demand
Analysis, Market Share, Market Report 2022-2027
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• Postmenopausal Hormone Therapy Market size is
  estimated to reach 46.5 billion by 2027, growing
  at a CAGR of 5.1 during the forecast period
  2022-2027. Postmenopausal Hormone Therapy
  includes medicines covering female hormones to
  take the place of the once the body no longer
  makes subsequent to menopause and is occasionally
  utilized to treat typical menopausal symptoms,
  inclusive of hot flashes and vaginal discomfort.
  Hormone therapy has also been confirmed to avert
  bone loss and decrease fractures in
  postmenopausal women.
• Atrophic vaginitis is normally associated with
  menopause and the related depleted levels of
  estrogen. Bazedoxifene is a novel SERM (Selective
  Estrogen Receptor Modulator) established by Wyeth
  Pharmaceuticals that is presently in phase III
  clinical trials for the avoidance and treatment
  of postmenopausal osteoporosis.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• Geographically, North America Postmenopausal
  Hormone Therapy Market accounted for the highest
  revenue share in 2021 and it is poised to
  dominate the market over the period 2022-2027
  owing to the soaring awareness regarding
  menopausal symptoms and great purchasing power in
  the North American region.
• Postmenopausal Hormone Therapy Market Detailed
  Analysis on the Strength, Weakness, and
  Opportunities of the prominent players operating
  in the market will be provided in the
  Postmenopausal Hormone Therapy Market report.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
Postmenopausal Hormone Therapy Market Segment
Analysis The Postmenopausal Hormone Therapy
Market based on therapy can be further segmented
into Estrogen, Progesterone, and
Estrogen-Progesterone Combinations. The Estrogen
Segment held the largest market share in 2021.
This growth is owing to the surging application
of Estrogen therapy in enhancing hormone levels
in women and decreasing menopausal symptoms like
hot flashes and others. Estrogen Therapy enhances
vaginal health by assisting in treating vaginal
issues like vaginal dryness. The extensive
advantages of Estrogen Therapy like safeguarding
bone loss subsequent to menopause and assistance
in handling ovary issues are further propelling
the growth of the Estrogen segment.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Postmenopausal Hormone Therapy Market Industry
  Outlook 
• Abbott Laboratories
• AbbVie, Inc.
• Bayer Pharma AG
• Meda pharmaceuticals
• Hisamitsu Pharmaceutical Co., Inc.

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Postmenopausal Hormone Therapy Market -
Forecast(2022 - 2027) Learn More About the
Report _at_ https//www.industryarc.com/purchaserep
ort.php?id16898
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_https//www.industryarc.com/
  purchasereport.php?id16898

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com